Accelerate Diagnostics, Inc. (AXDX) Financials

$1.17

north_east
$0.06 (5.41%)
Day's range
$1.1
Day's range
$1.24
$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80M-$100M-$100MEarning20172017201820182019201920202020202120212022202220232023-400%-400%-600%-600%-800%-800%-1000%-1000%-1200%-1200%-1400%-1400%-1600%-1600%Profit Margin
Profit Margin
Revenue
Earnings

AXDX Income statement / Annual

Last year (2023), Accelerate Diagnostics, Inc.'s total revenue was $12.06 M, a decrease of 5.43% from the previous year. In 2023, Accelerate Diagnostics, Inc.'s net income was -$61.62 M. See Accelerate Diagnostics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $12.06 M $12.75 M $11.78 M $11.17 M $9.30 M $5.67 M $4.18 M $246,000.00 $147,000.00 $122,000.00
Cost of Revenue $9.51 M $9.45 M $12.16 M $6.71 M $4.90 M $3.19 M $1.00 M $0.00 $0.00 $0.00
Gross Profit $2.55 M $3.30 M -$381,000.00 $4.46 M $4.40 M $2.48 M $3.18 M $246,000.00 $147,000.00 $122,000.00
Gross Profit Ratio 0.21 0.26 -0.03 0.4 0.47 0.44 0.76 1 1 1
Research and Development Expenses $25.35 M $26.92 M $21.94 M $21.26 M $25.35 M $27.64 M $22.30 M $28.20 M $26.02 M $20.05 M
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $31.23 M $39.19 M $49.24 M $46.90 M $51.89 M $55.21 M $45.06 M $36.20 M $17.88 M $10.70 M
Other Expenses $0.00 -$227,000.00 -$20,000.00 -$60,000.00 -$14,000.00 -$28,000.00 -$184,000.00 $2.35 M $1.79 M $888,000.00
Operating Expenses $56.58 M $66.11 M $71.18 M $68.16 M $77.23 M $82.85 M $67.36 M $66.75 M $45.70 M $31.64 M
Cost And Expenses $66.09 M $75.56 M $83.34 M $74.87 M $82.13 M $86.04 M $68.36 M $66.75 M $45.70 M $31.64 M
Interest Income $1.12 M $551,000.00 $88,000.00 $855,000.00 $2.81 M $2.85 M $908,000.00 $494,000.00 $74,000.00 $64,000.00
Interest Expense $7.74 M $3.77 M $15.55 M $15.55 M $14.26 M $10.11 M $0.00 $23,000.00 $23,000.00 $7,000.00
Depreciation & Amortization $3.25 M $3.00 M $2.52 M $3.00 M $2.60 M $2.56 M $2.20 M $2.35 M $1.79 M $888,000.00
EBITDA -$49.77 M -$55.80 M -$59.59 M -$59.66 M -$67.56 M -$75.44 M -$61.34 M -$64.15 M -$43.68 M -$30.10 M
EBITDA Ratio -4.13 -4.66 -5.85 -5.37 -7.25 -13.23 -15.35 -258.76 -297.16 -250.51
Operating Income Ratio -4.48 -4.93 -6.07 -5.71 -7.83 -14.17 -15.37 -270.33 -309.86 -258.34
Total Other Income/Expenses Net -$6.74 M $235,000.00 -$6.10 M -$14.50 M -$11.59 M -$7.75 M $649,000.00 $394,000.00 $51,000.00 -$470,000.00
Income Before Tax -$60.77 M -$62.57 M -$77.66 M -$78.20 M -$84.42 M -$88.12 M -$63.53 M -$66.11 M -$45.50 M -$31.46 M
Income Before Tax Ratio -5.04 -4.91 -6.59 -7 -9.08 -15.54 -15.21 -268.73 -309.51 -257.87
Income Tax Expense $850,000.00 -$77,000.00 $45,000.00 $5,000.00 -$111,000.00 $211,000.00 -$651,000.00 $267,000.00 $74,000.00 -$527,000.00
Net Income -$61.62 M -$62.49 M -$77.70 M -$78.21 M -$84.31 M -$88.33 M -$62.88 M -$66.37 M -$45.50 M -$30.93 M
Net Income Ratio -5.11 -4.9 -6.59 -7 -9.07 -15.58 -15.05 -269.81 -309.51 -253.55
EPS -4.94 -7.61 -12.59 -13.96 -15.47 -16.21 -11.63 -12.94 -10.11 -7.09
EPS Diluted -4.94 -7.61 -12.59 -13.96 -15.47 -16.21 -11.63 -12.94 -10.11 -7.09
Weighted Average Shares Out $12.48 M $8.22 M $6.17 M $5.60 M $5.45 M $5.45 M $5.41 M $5.13 M $4.50 M $4.36 M
Weighted Average Shares Out Diluted $12.48 M $8.22 M $6.17 M $5.60 M $5.45 M $5.45 M $5.41 M $5.13 M $4.50 M $4.36 M
Link